Shane Smith is the Managing Director of ExtLe (pronounced XTEL) Solutions Limited, a company based in Cambridge in the UK. He has over 35 years of experience in industrial analytical chemistry, with three quarters of that time spent in the pharmaceutical sector. As well as being an expert on extractables and leachables (E&L), he is a specialist in trace analysis and the separation sciences.
From 2004, he worked for GlaxoSmithKline’s world class E&L team at Stevenage in the UK, managing E&L projects for global cross-site project teams. He was ultimately responsibility for the E&L content of successful filings submitted to Regulatory Agencies across the world including North America, Europe, and other territories.
Shane left GlaxoSmithKline in early 2016 to pursue a career as an Independent Consultant and set up ExtLe Solutions to provide specialist E&L consultancy services.
With over 40 years’ combined experience dealing with E&Ls in an ever increasingly complex regulatory environment within the pharmaceutical industry, Shane and the team at ExtLe Solutions are able to apply best practise to vaping and e-liquid products, resulting in robust, scientifically sound E&L strategies for their clients’ products.